Go Pro

Corient Private Wealth LP Takes Position in The Ensign Group, Inc. $ENSG

The Ensign Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Corient Private Wealth acquired 10,610 shares of The Ensign Group in the second quarter, valued at approximately $1.7 million. Institutional investors collectively own 96.12% of ENSG, with BlackRock also initiating a major position.
  • Analysts maintain a “Moderate Buy” consensus, with an average price target of $216.25; targets range from $207 to $228, although some firms recently downgraded their ratings to Hold or reduced their Buy grades.
  • The company exceeded quarterly earnings expectations, reporting $1.92 in EPS versus the $1.80 consensus, while revenue rose 16.7% year over year to $1.44 billion. ENSG also declared a quarterly dividend of $0.065 per share, producing a 0.2% annualized yield.
  • Interested in The Ensign Group? Here are five stocks we like better.

Corient Private Wealth LP acquired a new position in shares of The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 10,610 shares of the company's stock, valued at approximately $1,701,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ENSG. BlackRock Inc. acquired a new position in The Ensign Group during the 2nd quarter worth $937,218,000. Wasatch Advisors LP raised its stake in shares of The Ensign Group by 6.0% during the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company's stock valued at $548,961,000 after purchasing an additional 199,983 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of The Ensign Group by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company's stock valued at $261,107,000 after purchasing an additional 49,117 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in The Ensign Group by 9.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company's stock worth $232,124,000 after purchasing an additional 118,110 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in The Ensign Group by 0.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,090,838 shares of the company's stock valued at $190,033,000 after buying an additional 5,458 shares in the last quarter. 96.12% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on ENSG shares. Wall Street Zen cut shares of The Ensign Group from a "buy" rating to a "hold" rating in a research note on Saturday, July 25th. Truist Financial upped their price target on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a "hold" rating in a research note on Thursday, July 30th. Weiss Ratings cut shares of The Ensign Group from a "buy (b)" rating to a "buy (b-)" rating in a report on Tuesday, June 16th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $228.00 price objective on shares of The Ensign Group in a research note on Tuesday, July 28th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $216.25.

View Our Latest Report on ENSG

The Ensign Group Price Performance

Shares of NASDAQ:ENSG opened at $172.09 on Friday. The Ensign Group, Inc. has a one year low of $141.58 and a one year high of $218.00. The stock has a fifty day moving average of $174.30 and a 200-day moving average of $183.03. The company has a market capitalization of $10.03 billion, a PE ratio of 26.97, a price-to-earnings-growth ratio of 1.66 and a beta of 0.69. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last issued its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.80 by $0.12. The business had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.44 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The company's quarterly revenue was up 16.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. As a group, equities analysts anticipate that The Ensign Group, Inc. will post 6.93 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were paid a $0.065 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The Ensign Group's dividend payout ratio (DPR) is currently 4.08%.

Insiders Place Their Bets

In other The Ensign Group news, Director John Agwunobi sold 392 shares of the business's stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the sale, the director owned 9,503 shares in the company, valued at approximately $1,625,583.18. The trade was a 3.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.00% of the company's stock.

About The Ensign Group

(Free Report)

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company's model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

Read More

Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG - Free Report).

Institutional Ownership by Quarter for The Ensign Group (NASDAQ:ENSG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in The Ensign Group Right Now?

Before you consider The Ensign Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Ensign Group wasn't on the list.

While The Ensign Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines